Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Lewis Tanya
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-05-16
Sale
2022-05-18
7:02 pm
Replimune Group Inc. REPL Lewis Tanya
Chief Dev. Op Officer
5,473 $14.59 $79,851 120,360
(Direct)
View
2021-02-11
Sale
2021-02-17
6:49 pm
Karyopharm Therapeutics Inc. KPTI Lewis Tanya
EVP Chief Reg. Affairs
2,046 $15.52 $31,752 4,143
(Direct)
View
2020-10-28
Sale
2020-11-04
8:18 pm
Karyopharm Therapeutics Inc. KPTI Lewis Tanya
EVP Chief Reg. & Quality Officer
226 $15.58 $3,521 2,834
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-04-01
Option Award
2022-04-05
4:15 pm
N/A
2032-04-01
Replimune Group Inc. REPL Lewis Tanya
Chief Dev.Op Off
131,250 $0 204,583
(Direct)
View
2021-05-10
Option Award
2021-05-11
9:01 pm
N/A
2031-05-10
Replimune Group Inc. REPL Lewis Tanya
Chief Dev. Oper. Off.
183,333 $0 183,333
(Direct)
View
2021-04-01
Option Award
2021-04-05
8:14 pm
N/A
2031-04-01
Replimune Group Inc. REPL Lewis Tanya
Director
16,500 $0 16,500
(Direct)
View
2021-02-25
Option Award
2021-03-01
8:13 pm
N/A
2031-02-24
Karyopharm Therapeutics Inc. KPTI Lewis Tanya
EVP Chief Reg. Affairs
81,981 $0 105,369
(Direct)
View
2021-02-05
Exercise
2021-02-09
8:34 pm
N/A
N/A
Karyopharm Therapeutics Inc. KPTI Lewis Tanya
EVP Chief Reg. Affairs
5,650 $0 23,139
(Direct)
View
2020-10-28
Exercise
2020-11-04
8:18 pm
N/A
N/A
Karyopharm Therapeutics Inc. KPTI Lewis Tanya
EVP Chief Reg. & Quality Officer
765 $0 2,834
(Direct)
View
2020-11-02
Option Award
2020-11-03
4:07 pm
N/A
2030-11-02
Replimune Group Inc. REPL Lewis Tanya
Director
33,000 $0 33,000
(Direct)
View
2020-02-05
Option Award
2020-02-07
4:21 pm
N/A
2030-02-04
Karyopharm Therapeutics Inc. KPTI Lewis Tanya
EVP Chief Reg. & Quality Officer
83,200 $0 83,200
(Direct)
View
2019-10-30
Ownership
2019-11-05
4:44 pm
N/A
2028-11-29
Karyopharm Therapeutics Inc. KPTI Lewis Tanya
EVP Chief Reg. & Quality Officer
0 $0 117,530
(Direct)
View